Chronic phase of Chagas disease: why should it be treated? A comprehensive review José Rodrigues Coura ; José Borges-Pereira PAGE: 641-645 | DOI: 10.1590/S0074-02762011000600001

Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes Fernanda de Aquino Marinho; Keyla Cristiny da Silva Gonçalves; Selma Soares de Oliveira; Ana-Carolina de Siqueira Couto de Oliveira; Maria Bellio; Claudia Masini d'Avila-Levy; André Luis Souza dos Santos; Marta Helena Branquinha PAGE: 507-509 | DOI: 10.1590/S0074-02762011000400021

Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations Dhamodharan Ramasamy; Hoti Sugeerappa Laxmanappa; Rohit Sharma; Manoj Kumar Das PAGE: 240-247 | DOI: 10.1590/S0074-02762011000200020

The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice Danilo Ciccone Miguel; Marcela Lencine Ferraz; Rosana de Oliveira Alves; Jenicer KU Yokoyama-Yasunaka; Ana Claudia Torrecilhas; Alvaro José Romanha; Silvia RB Uliana PAGE: 945-948 | DOI: 10.1590/S0074-02762010000700021

Antibody reactivity against potato apyrase, a protein that shares epitopes with Schistosoma mansoni ATP diphosphohydrolase isoforms, in acute and chronically infected mice, after chemotherapy and reinfection Priscila de Faria-Pinto; Maria Ângela Montesano; Alexandre Arthur Jacinto; Ronaldo Soares Santos; Fábio Humberto S Bordin; Ana Paula Ferreira; Marcus Luiz O Penido; Paulo Marcos Z Coelho; Eveline G Vasconcelos PAGE: 374-379 | DOI: 10.1590/S0074-02762010000400005

The spatial distribution of Schistosoma mansoni infection before and after chemotherapy in the Jequitinhonha Valley in Brazil Andrea Gazzinelli; Allen Hightower; Philip T LoVerde; João Paulo Amaral Haddad; Wesley Rodrigues Pereira; Jeffrey Bethony; Rodrigo Correa-Oliveira; Helmut Kloos PAGE: 63-71 | DOI: S0074-02762006000900010

The biological in vitro effect and selectivity of aromatic dicationic compounds on Trypanosoma cruzi Cristiane França da Silva; Patrícia Bernadino da Silva; Marcos Meuser Batista; Anissa Daliry; Richard R Tidwell; Maria de Nazaré Correia Soeiro PAGE: 239-245 | DOI: 10.1590/S0074-02762010000300001

Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi  Momodou Jobe; Charles Anwuzia-Iwegbu; Ama Banful, Emma Bosier; Mubeen Iqbal; Kelly Jones; Suzanne J Lecutier; Kasimir Lepper; Matt Redmond; Andrew Ross-Parker; Emily Ward; Paul Wernham; Eleanor M Whidden; Kevin M Tyler; Dietmar Steverding PAGE: 946-950 | DOI: 10.1590/S0074-02762012000700018

The resumption of consumption – a review on tuberculosis Rodrigo Gay Ducati; Antonio Ruffino-Netto; Luiz Augusto Basso; Diógenes Santiago Santos PAGE: 697-714 | DOI: S0074-02762006000700001

Ergosterol biosynthesis and drug development for Chagas disease Julio A Urbina PAGE: 311-318 | DOI: 10.1590/S0074-02762009000900041

Present situation and new strategies for Chagas disease chemotherapy - a proposal José Rodrigues Coura PAGE: 549-554 | DOI: 10.1590/S0074-02762009000400002

Anti-mycobacterial treatment reduces high plasma levels of CXC-chemokines detected in active tuberculosis by cytometric bead array Caroline de Souza Almeida; Clarice Abramo; Caio César de Souza Alves; Luciano Mazzoccoli; Ana Paula Ferreira; Henrique Couto Teixeira PAGE: 1039-1041 | DOI: 10.1590/S0074-02762009000700018

Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice Renata Siqueira Portella; Sonia G Andrade PAGE: 1023-1030 | DOI: 10.1590/S0074-02762009000700015

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations Constança Carvalho Britto PAGE: 122-135 | DOI: 10.1590/S0074-02762009000900018

Imatinib activity on Schistosoma mansoni Naftale Katz, Flávia Fernanda Bubulo Couto, Neusa Araújo PAGE: 850-853 | DOI: 10.1590/0074-0276130207

In Vitro Activity of Etanidazole against the Protozoan Parasite Trypanosoma cruzi Patricia B Petray, María J Morilla*, Ricardo S Corral, Eder L Romero* PAGE: 233-235

Diterpenoids from Azorella compacta (Umbelliferae) Active onTrypanosoma cruzi Jorge E Araya, Iván Neira, Solange da Silva, Renato A Mortara, Patricio Manque, Esteban Cordero, Hernán Sagua, Alberto Loyola, Jorge Bórquez,Glauco Morales, Jorge González PAGE: 413-418

A Critical Review on Chagas Disease Chemotherapy José Rodrigues Coura, Solange L de Castro* PAGE: 3-24

Variation in Susceptibility to Benznidazole in Isolates Derived from Trypanosoma cruzi Parental Strains VM Veloso, CM Carneiro, MJO Toledo, M Lana, E Chiari, WL Tafuri,MT Bahia PAGE: 1005-1011

The Role of the Scientific Research in the Control of Schistosomiasis in Endemic Areas Aluízio Prata PAGE: 5-11

Replacing Oxamniquine by Praziquantel against Schistosoma mansoni Infection in a Rural Community from the Sugar-cane Zone of Northeast Brazil: an Epidemiological Follow-up Lilian Beck, Tereza Cristina Favre, Otávio Sarmento Pieri, Luciana Carvalho Zani, Glauce Gajo Domas, Constança Simões Barbosa PAGE: 165-167

Schistosomiasis Control Based on Repeated Chemotherapy in a Rural Village of the Sugar-Cane Zone in Northeast Brazil Otávio S Pieri/, Constança S Barbosa*, Patrícia G Moza PAGE: 259-264

The Situation of Hepatosplenic Schistosomiasis in Brazil Today Zilton A Andrade PAGE: 313-316

Sensitivity of Leishmania spp. to Glibenclamide and 4-Aminopiridine: A Tool for the Study of Drug Resistance Development Alicia Ponte-Sucre, Yelitza Campos, Jorge Vázquez, Heidrun Moll, Alexis Mendoza-León PAGE: 601-606

In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195 Carlos Eduardo Sampaio Guedes, Beatriz Rocha Simões Dias, Antonio Luis de Oliveira Almeida Petersen, Kercia Pinheiro Cruz, Niara de Jesus Almeida, Daniela Rodrigues Andrade, Juliana Perrone Bezerra de Menezes, Valéria de Matos Borges, Patricia Sampaio Tavares Veras DOI: 10.1590/0074-02760170345

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection Cynthia M Cascabulho, Marcelo Meuser-Batista, Kelly Cristina G de Moura, Maria do Carmo Pinto, Thabata Lopes Alberto Duque, Kelly C Demarque, Ana Carolina Ramos Guimarães, Pedro Paulo de Abreu Manso, Marcelo Pelajo-Machado, Gabriel M Oliveira, Solange L De Castro, Rubem FS Menna-Barreto DOI: 10.1590/0074-02760190389

Is the mitochondrion a promising drug target in trypanosomatids? Yasmin Pedra-Rezende, Ana Cristina Souza Bombaça, Rubem Figueiredo Sadok Menna-Barreto DOI: 10.1590/0074-02760210379

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy Ana Maria Murta Santi, Silvane Maria Fonseca Murta DOI: 10.1590/0074-02760210401

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors Leandro Stefano Sangenito, Claudia Masini d’Avila-Levy, Marta Helena Branquinha, André Luis Souza dos Santos DOI: 10.1590/0074-02760210386